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Abstract
Many lines of evidence suggest that the retinoblastoma protein inter-
acting zinc finger gene RIZ is a strong candidate for the tumor suppressor
locus on 1p36, a region commonly deleted in many human cancers with
chromosomal instability. In addition, a role for RIZ in tumors of the
microsatellite instability pathway is suggested by frequent frameshift
mutations in hereditary non-polyposis colorectal carcinomas. Here we
studied RIZ mutations in sporadic cancers with microsatellite instability.
Frameshift mutations in the two coding polyadenosine tracks of RIZ were
found in 19 (48%) of 40 gastric carcinomas, 6 (33%) of 18 endometrial
carcinomas, 14 (26%) of 51 of colorectal carcinomas, and 7 (54%) of 13
cell lines. Eleven tumor tissues showed biallelic inactivation of RIZ. In
contrast, no frameshift mutations were found in 70 microsatellite stable
tumors. These results suggest an important role for RIZ in sporadic
cancers with microsatellite instability.
Introduction
It is now widely accepted that cancer is the result of an accumu-
lation of mutations in cellular cancer-causing genes. The mutations
are thought to be driven by genetic instabilities, which commonly
characterize tumor cells. Two major pathways of instabilities have
been recognized, CIN3 and MIN (1). The hallmarks of tumors of the
CIN pathway are aneuploidy and LOH. In contrast, tumors of the MIN
pathway are usually diploid and show massive instability in simple
repeated sequences or microsatellites. In addition, epigenetic events
can also facilitate genetic damage, as illustrated by the increased
mutagenicity of 5-methylcytosine and the silencing of the MLH1
mismatch repair gene by DNA methylation in colorectal tumors (2).
MSI-positive (1) tumors are caused by defects in the mismatch
repair system (3–5). MSI has been detected in HNPCC and HNPCC-
associated tumors such as gastric carcinomas and endometrial carci-
nomas, as well as in many sporadic cases of these tumors (6). The
mechanism of tumorigenesis of MSI(1) tumors is thought to involve
frameshift mutations of microsatellite repeats within coding regions of
affected target genes the inactivation of which directly contributes to
tumor development (7).
The retinoblastoma protein-interacting zinc finger gene RIZ is a
candidate tumor suppressor gene belonging to the PR or SET domain
family of chromosomal regulators involved in chromatin-mediated
gene activation and silencing (8, 9). The PR domain of RIZ is a
protein-binding interface and can interact with a motif present in the
COOH region of RIZ (9). The PR/SET domain family plays an
important role in human cancers as evidenced by genetic mutations of
several family members (10). RIZ gene normally produces two protein
products, RIZ1 and RIZ2, that differ at the NH2-region by the pres-
ence or absence of the PR domain (11). The RIZ1 (PR1) product is
considered a strong candidate for the tumor suppressor(s) on 1p36, a
region commonly deleted in more than a dozen different types of
human cancers (12). RIZ1 gene expression but not RIZ2 is commonly
silenced in all of the human cancers examined including those of
breast, liver, colon, and neuroendocrine tissues (13, 14). Consistently,
RIZ1 has the capacity to induce G2-M cell cycle arrest, apoptosis, or
both, and tumor suppression in mice (13, 14). These observations
suggest a role for RIZ in many tumors of the CIN pathway.
RIZ also appears to play an important role in hereditary tumors of
the MIN pathway as suggested by the frequent frameshift mutations in
HNPCC tumors (15). The mutations are located at two polyadenosine
tracks within the coding region of RIZ: one (A)8 track at coding
nucleotide position 4273–4280 and one (A)9 track at 4462–4471 in
exon 8. These mutations generate truncated RIZ1/2 proteins lacking
the COOH-terminal PR-binding motif and are expected to have seri-
ous deleterious effects on the PR domain-specific function of RIZ1.
Hereditary and sporadic MSI(1) colorectal carcinomas are caused
by different tumorigenic events. Genetic defects in MSH2 and MSH3
causes HNPCC, and epigenetic silencing of MLH1 is associated with
MSI(1) sporadic colorectal carcinomas (2). The role of RIZ in spo-
radic MSI(1) tumors remains to be investigated. Here we describe
frequent frameshift mutations of RIZ in sporadic gastrointestinal and
endometrial cancers. Importantly, many of these were biallelic or
homozygous/hemizygous mutations, which suggests that RIZ inacti-
vation is highly selected during the clonal evolution of these tumors.
Materials and Methods
Cell Lines and Tumor Samples. Fourteen cell lines were purchased from
American Type Culture Collection. These were derived from colon (HCT116,
SW-48, LOVO, LS441N, LS180, LS174T, DLD1, HCT15, HCT8), prostate
(DU145), breast (Cal-51), and uterus (AN3CA, SK-UT-1B) cancers. MSI(2)
colon cancer cell line SW620 was also included as controls. A total of 179
primary gastrointestinal and endometrial tumors from patients undergoing
surgery were analyzed. Among them, 109 tumors were characterized as MSI-
High including 40 gastric carcinomas, 18 endometrial cancers, and 51 colo-
rectal cancers. The source of tumor samples has been described previously
(16–18).
Analysis of MSI. MSI-High status in primary tumors was defined accord-
ing to the criteria proposed by Boland et al. (19).
Mutation Analysis of RIZ. Frameshift mutations at (A)8 and (A)9 tracks in
the RIZ were detected by PCR with Vent DNA polymerase and SSCP analysis,
followed by sequencing. The (A)8 track was amplified by PCR with primers
RIZA8-F, 59-GAGCTCAGCAAAATGTCGTC-39, and RIZA9-R, 59-CAAG-
TCGGCCTTCTGCTTTG-39. The (A)9 track was amplified by PCR with
primers RIZA9-F, 59-TCTCACATCTGCCCTTACTG-39, and RIZA9-R, 59-
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Table 1 Frameshift mutations of RIZ in gastric carcinomas, endometrial carcinomas, and colorectal cancers and cell lines with MSI
Sample Tissue type
Pro704
RIZ mutationAllele 1 Allele 2
KS02 Gastric Ia (A)9DA
I
KS06 Gastric NI (A)9DA
NI
KS07 Gastric (A)9DA
LOH
KS12 Gastric NI (A)9DA
NI
KS15 Gastric NI (A)9DA
NI (A)9DA
KS18 Gastric NI (A)9DAA
NI
KS19 Gastric NI (A)9DA
NI (A)8DA; (A)9DA
KS20 Gastric (A)9DA
LOH
KS21 Gastric I (A)9DA
I
KS22 Gastric ND (A)9DA
ND
KS25 Gastric I (A)9DA
I
KS31 Gastric NI (A)9DAA
NI
KS33 Gastric I (A)9DA
I
KS34 Gastric NI (A)9DA
NI
KS36 Gastric NI (A)9DA
NI
E4 Endometrial ND (A)9DA
ND (A)9DAA
E55 Endometrial ND (A)9DA
ND
E67 Endometrial ND (A)9DA
ND
E68 Endometrial ND (A)9DA
ND (A)9DAA
E75 Endometrial ND (A)9DAA
ND (A)8DA
E505 Endometrial ND (A)9DAA
ND (A)9DAA
AC61 Colon NI (A)9DA
NI (A)9DA
AC149 Colon NI (A)9DA
NI
AC334 Colon ND (A)8DA; (A)9DA(A)9DA
AC353 Colon ND (A)9DA
AC410 Colon I (A)9DAA
I
AC411 Colon NI (A)9DA
NI
AC469 Colon I (A)9DA
I (A)9DA
AC558 Colon I (A)9DA
I
AC584 Colon I (A)8DA
I
AC590 Colon NI (A)9DA
NI
IC31 Colon ND (A)9DA
ND
IC70 Colon ND (A)9A
ND
IC824 Colon ND (A)9DAA
ND
IC2513 Colon ND (A)9DA
ND
AS95 Colon I (A)9DA
I
AS109 Colon I (A)9DA
I
AS111 Colon NI (A)9DA
NI
HCT116 Colon ND (A)9DA
ND (A)9DA
LOVO Colon ND (A)9DA
ND
LS411N Colon ND (A)9DA
ND
LS180 Colon ND (A)9DA
ND
LS174T Colon ND (A)9DA
ND
HCT-8 Colon ND (A)9DA
ND
AN3CA Endometrium ND (A)9DA
ND (A)9DAA
a I, informative; NI, not informative; ND, not determined; DA, deletion of one A.
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GTGATGAGTGTCCACCTTTC-39. PCR was carried out with Vent DNA
polymerase as described previously (17). PCR was performed with primers
RIZA8-F and RIZA-9R for SSCP analysis as described (17). The mutated
bands in SSCP gel were sequenced using the Big Dye terminator cycle
sequencing kit (Perkin-Elmer Corp.).
Assessment of LOH. The RIZ Pro704 deletion polymorphism, which has
been discovered during sequence analysis of RIZ, was assayed by PCR, then
followed by electrophoresis on denaturing gel as described previously (20).
The PCR primers were RP145 (59-CCC AAG ATA AAC TAA CTC CT-39)
and RP105 (59-ACT CCA TGC TGG TGA GTC-39).
Results and Discussion
We detected RIZ mutations in 19 (48%) of 40 MSI(1) gastric
carcinomas, 6 (33%) of 18 endometrial cancers, 14 (26%) of 51
colorectal carcinomas, and 7 (54%) of 13 MSI(1) cell lines (Fig. 1
and Table 1). Some of the cell lines have also been studied by
Chadwick et al. (15) and served as positive control for our studies
here. The mutations found in tumor tissues were somatic because the
corresponding normal counterparts were wild type. With the excep-
tion of a mutation in the (A)8 track in KS19, E75, AC334, and AC590,
all of the mutations targeted the (A)9 track. No mutations in the (A)8
or (A)9 track were found in 70 MSI(2) gastric carcinomas, which
indicated that these mutations are specific for MSI(1) tumors (46/122
versus 0/70; P 5 0.000000 by Fisher’s exact test).
Among the 46 cases with RIZ mutations (7 cell lines, 19 gastric
carcinomas, 6 endometrial carcinomas, and 14 colorectal carcinomas),
11 cases (KS15, KS19, E4, E68, E75, E505, AC91, AC334, AC469,
HCT-116, AN3CA) were biallelic mutations. KS15, E68, E505,
AC91, AC469, and HCT-116 showed homozygous/hemizygous mu-
tations (Fig. 1 and Table 1). KS19 and AC334 had a 1-bp deletion at
both (A)9 and (A)8 tracks in one allele and a 1-bp deletion at (A)9
track in the other allele, whereas E4 and AN3CA showed a 1-bp
deletion at (A)9 track in one allele and a 2-bp deletion at (A)9 track in
the other allele. E75 had a 1-bp deletion at (A)8 track in one allele and
2-bp deletion at (A)9 track in the other allele. To determine whether
RIZ is also affected by chromosomal deletions in MSI(1) cancers,
LOH studies were performed on 25 cases with frameshift mutations
for which the matched normal DNAs were available. The RIZpro704
deletion polymorphism, a three-nucleotide deletion at codon Pro704
in exon 8 (20), allowed us to detect LOH in 2 of 12 informative
tumors, KS07 and KS20, which had frameshift mutations in one allele
(Table 1). Therefore, 11 cancers (KS07, KS15, KS19, KS20, E4, E68,
E75, E505, AC91, AC334, AC469) and 2 cell lines (HCT-116,
AN3CA) had evidence of biallelic inactivation of RIZ. The high
frequency of mutation and biallelic inactivation suggest that frame-
shift mutation of RIZ is clonally selected during tumorigenesis.
All of the frameshift mutations here found in RIZ are predicted to
lead to the production of the COOH-terminal domain truncated pro-
teins. The deletion of one adenosine in the (A)8 track at amino acid
residue 1436 produces a stop codon two residues from the deletion
and a mutant protein lacking COOH-terminal 293 amino acids. It has
been demonstrated that the COOH-terminal domain (amino acid
1502–1668 of RIZ1) is a PR domain-binding motif, which may play
a role in RIZ1 folding or binding to other proteins or RIZ1 itself
(oligomerizaton; 9). Thus, deletion of this COOH-terminal protein-
binding interface is likely to seriously affect RIZ1 functions.
Our results show that RIZ frameshift mutations are common in
sporadic MSI(1) cancers, including gastric, endometrial, and colo-
rectal carcinomas. Importantly, many of these mutations are biallelic
or homozygous/hemizygous, which suggests that RIZ fits the Knud-
son’s two-hit model of tumor suppressor genes (21). Given the char-
acteristic low frequency of LOH in MSI(1) tumors, it is not surprising
that LOH is not commonly found at the RIZ locus in these tumors.
Future studies will be required to determine whether other genetic or
epigenetic events may be responsible for the inactivation of the
remaining wild-type allele. Biallelic inactivation of RIZ was not found
in the recent study on HNPCC tumors (15). This may be related to the
genetic differences between hereditary and sporadic cancers but more
extensive studies on HNPCC will be required to determine whether
heterozygous RIZ mutation is a characteristic of this tumor.
Together with the location on 1p36 and the silencing in many
cancers, our finding here suggests that RIZ is a common target of both
the CIN and MIN pathways of cancer. In view of the recent report of
a role of RIZ in estrogen-receptor signaling (22), our finding of RIZ
mutation in endometrial carcinomas is consistent with an important
role in the hormone-dependent growth-control pathways in the endo-
metrium.
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